Latest New England Journal Stories
Use of a twice-daily pill could turn a deadly blood cancer into a highly treatable disease.
A major trial aiming to cut the rate of tuberculosis (TB) among South Africa's gold miners did not reduce the number of cases or deaths from the disease.
The U.S. should prepare for more outbreaks of illness and possible deaths from designer drugs including synthetic marijuana.
Adverse Events for Heart Attack, Heart Failure Decline; Improvements Lag for Pneumonia and Surgical Patients Wethersfield, CN (PRWEB) January 23, 2014
A team of scientists from the University of Leicester has demonstrated a novel treatment for Hairy Cell Leukaemia (HCL), a rare type of blood cancer, using a drug administered to combat skin cancer.
An endotracheal extubation training video produced by Rafael Ortega, MD, the vice-chair of academic affairs for the department of anesthesiology at Boston Medical Center (BMC) and professor of anesthesiology at Boston University School of Medicine (BUSM), and his colleagues is featured in this week's New England Journal of Medicine.
Efforts to cure hepatitis C, the liver-damaging infectious disease that has for years killed more Americans than HIV/AIDS, are about to get simpler and more effective.
Being overweight or obese does not lead to improved survival among patients with type 2 diabetes.
Results published in a new study in the Jan. 9 issue of the New England Journal of Medicine report that mild electronic stimulation therapy to the upper airway during sleep is effective in reducing obstructive sleep apnea (OSA).
Fertility technology in the United States has a huge influence on the frequency of twins, triplets, and other multiple births.
- A trick or prank.